Evidence map›Paper›PMID 41100689›Full record

ArticleTechnology in cancer research & treatment

Retrospective Analysis of CT-based Habitat Analysis for Predicting pCR and Survival of ESCC Treated by Neoadjuvant Chemoradiotherapy and Esophagectomy.

Shujun Zhang, Wei-Xiang Qi, Feng Wang, Yibin Zhang, Jiayi Chen, Shengguang Zhao

Abstract read
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shujun ZhangDepartment of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Wei-Xiang QiDepartment of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.ORCID 0000-0001-5484-3343
Feng WangDepartment of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Yibin ZhangDepartment of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Jiayi ChenDepartment of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.ORCID 0000-0001-6417-290X
Shengguang ZhaoDepartment of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IntroductionThis study sought to develop a predictive model using CT-based habitat radiomics to forecast pathological complete response (pCR) and progression-free survival (PFS) in esophageal squamous cell carcinoma (ESCC) patients receiving standardized neoadjuvant chemoradiotherapy (nCRT) followed by curative surgery.MethodsWe retrospectively analyzed baseline CT imaging data from 228 ESCC patients in a prospective cohort database. Patients were randomly divided into training and validation sets (7:3 ratio). Whole-tumor and habitat-derived radiomic features were extracted from pretreatment CT scans. For pCR prediction, habitat signatures were developed using Logistic Regression (LR), RandomForest (RF), and XGBoost models, optimized via grid search. PFS prediction employed Cox proportional hazards modeling with selected features. Model performance was assessed using the area under the receiver operating characteristic curve (AUC), Hosmer-Lemeshow calibration curves, and decision curve analysis.ResultsThe habitat models retained 10 features for pCR prediction and 12 for PFS prediction. For pCR, the habitat-derived RF model demonstrated superior performance (training AUC: 0.821; validation AUC: 0.826), outperforming both other habitat models and the whole-tumor radiomics model (training AUC: 0.645). Similarly, the habitat-based RF model for PFS achieved higher AUCs (training: 0.759, 95% CI: 0.627-0.889; validation: 0.810, 95% CI: 0.653-0.966) compared to whole-tumor radiomics (training: 0.623; validation: 0.519).ConclusionOur analyses indicated a trend where habitat radiomics

Indexed as

Esophageal NeoplasmsEsophageal Squamous Cell CarcinomaEsophagectomyTomography, X-Ray ComputedAgedChemoradiotherapyFemaleHumansMaleMiddle AgedNeoadjuvant TherapyPrognosisRetrospective StudiesROC CurveTreatment Outcomeesophageal squamous cell carcinomahabitat imagingneoadjuvant chemoradiotherapypathological complete responseradiomicssurvival

Identifiers

PMID41100689
PMCPMC12536188

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.